Hitachi Develops AI Technology to Support Pre-preparation for Expert Panels in Cancer Genomic Medicine
NQ Score
50/100
AI Summary (NQ-processed)
Hitachi has developed AI technology to support the pre-preparation of expert panels for cancer genomic medicine.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Which organizations developed the AI technology to support the pre-preparation for Expert Panels?
- A: Tohoku University Hospital, Hitachi, and Hitachi High-Tech developed the AI technology.
- Q: What is the purpose of the Expert Panels (EP) in cancer genomic medicine?
- A: Expert Panels are specialized meetings for the medical interpretation of genetic test results.
- Q: What reference data does the AI technology use to present points for confirmation and discussion?
- A: The technology refers to past physician comments, related knowledge, and literature databases.
- Q: Where is the AI system designed to operate, and how does it handle sensitive information?
- A: The system is designed to operate on PCs within the hospital, assuming no external transmission of sensitive information.
- Q: What was the matching rate in the evaluation of the AI technology using past Tohoku University Hospital cases?
- A: Over 80% of the points presented by this technology matched the Expert Panel's review results.